As Alzheimer’s disease and ITM2B/BRI2-related familial dementias share common clinical and neuropathological features, including amyloid depositions (12, 25, –27), we evaluated whether the impact of mutations on amyloid nucleation of ADan depends on similar properties as those driving Aβ42 nucleation. This evidence concerns the gene ITM2B and Alzheimer disease.